Literature DB >> 11121308

Structure and molecular mechanism of a functional form of pneumolysin: a cholesterol-dependent cytolysin from Streptococcus pneumoniae.

S J Kelly1, M J Jedrzejas.   

Abstract

One of the key steps in understanding human disease arising from gram-positive bacteria lies in the mechanisms of the cholesterol-dependent cytolysins (CDCs). Pneumolysin (PLY), a CDC from Streptococcus pneumoniae, is of special importance due to the severe impacts of pneumococcal infections on mortality and morbidity worldwide. We have overexpressed, purified, and characterized PLY in its fully functional complex form with the enzyme bound to its receptor activator on target cells, cholesterol. The circular dichroism studies of PLY in solution with an excess of cholesterol show a change in the far UV spectrum consistent with a decrease in the beta-sheet and an increase in the random coil structures of the enzyme. Pore formation in membranes leading to cell lysis is the functional target for this cytolysin. The sedimentation velocity and equilibrium analyses of the cholesterol-bound enzyme show hydrodynamic properties different from those of the cholesterol-free form. The soluble form of the cholesterol-free enzyme exists in solution as a mixture of monomers and dimers, whereas the cholesterol-bound form exists only as a monomer. A mechanism of formation of PLY pores in the lipid bilayer of the target cells is discussed. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121308     DOI: 10.1006/jsbi.2000.4308

Source DB:  PubMed          Journal:  J Struct Biol        ISSN: 1047-8477            Impact factor:   2.867


  13 in total

1.  Immunization with pneumolysin protects against both retinal and global damage caused by Streptococcus pneumoniae endophthalmitis.

Authors:  Melissa E Sanders; Erin W Norcross; Quincy C Moore; Jonathan Fratkin; Hilary Thompson; Mary E Marquart
Journal:  J Ocul Pharmacol Ther       Date:  2010-10-29       Impact factor: 2.671

Review 2.  Pneumococcal virulence factors: structure and function.

Authors:  M J Jedrzejas
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

3.  The role of cholesterol in the activity of pneumolysin, a bacterial protein toxin.

Authors:  Marcelo Nöllmann; Robert Gilbert; Timothy Mitchell; Michele Sferrazza; Olwyn Byron
Journal:  Biophys J       Date:  2004-05       Impact factor: 4.033

4.  Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with Streptococcus pneumoniae in vitro: a novel function of pneumolysin in caspase-1 activation.

Authors:  Shereen Shoma; Kohsuke Tsuchiya; Ikuo Kawamura; Takamasa Nomura; Hideki Hara; Ryosuke Uchiyama; Sylvia Daim; Masao Mitsuyama
Journal:  Infect Immun       Date:  2008-01-14       Impact factor: 3.441

5.  Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.

Authors:  Mary E Marquart; Kathryn S Monds; Clare C McCormick; Sherrina N Dixon; Melissa E Sanders; Julian M Reed; Larry S McDaniel; Armando R Caballero; Richard J O'Callaghan
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

6.  Experimental design approach in recombinant protein expression: determining medium composition and induction conditions for expression of pneumolysin from Streptococcus pneumoniae in Escherichia coli and preliminary purification process.

Authors:  Guillermo Marini; Mateus Dalcin Luchese; Ana Paula Correa Argondizzo; Ana Carolina Magalhães Andrade de Góes; Ricardo Galler; Tito Lívio Moitinho Alves; Marco Alberto Medeiros; Ariane Leites Larentis
Journal:  BMC Biotechnol       Date:  2014-01-09       Impact factor: 2.563

Review 7.  Proteomics in the Study of Bacterial Keratitis.

Authors:  Rachida Bouhenni; Jeffrey Dunmire; Theresa Rowe; James Bates
Journal:  Proteomes       Date:  2015-12-14

8.  Insights into structure and activity of natural compound inhibitors of pneumolysin.

Authors:  Hongen Li; Xiaoran Zhao; Xuming Deng; Jianfeng Wang; Meng Song; Xiaodi Niu; Liping Peng
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

9.  Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.

Authors:  Melissa E Sanders; Sidney Taylor; Nathan Tullos; Erin W Norcross; Quincy C Moore; Hilary Thompson; Lauren B King; Mary E Marquart
Journal:  BMC Ophthalmol       Date:  2013-03-11       Impact factor: 2.209

10.  Induction of Central Host Signaling Kinases during Pneumococcal Infection of Human THP-1 Cells.

Authors:  Thomas P Kohler; Annemarie Scholz; Delia Kiachludis; Sven Hammerschmidt
Journal:  Front Cell Infect Microbiol       Date:  2016-04-26       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.